theres only 3 companies that produce it , Eli Lily, sanofi aventis and novo nordisk, they have fought aggressively through litigation in the past to prevent any insulin generic, or biosimilar to reach the market. they agreed amongst themselves to have whatever the cost they want without competing with each other.
Tollana1234567@lemmy.today 10 months ago
theres only 3 companies that produce it , Eli Lily, sanofi aventis and novo nordisk, they have fought aggressively through litigation in the past to prevent any insulin generic, or biosimilar to reach the market. they agreed amongst themselves to have whatever the cost they want without competing with each other.
Spitefire@lemmy.world 10 months ago
Civica is launching insulin glargine in early 2026 specifically because of that bullshit.
fullsquare@awful.systems 10 months ago
good. generic biosimilars cost like 1/5 of the on-patent thing price